Page last updated on March 19, 2025
scPharmaceuticals Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2025-03-19 17:20:48 EDT.
Filings
10-K filed on 2025-03-19
scPharmaceuticals Inc. filed a 10-K at 2025-03-19 17:20:48 EDT
Accession Number: 0000950170-25-042159
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cyberse curity. Cybersecurity Risk Management and Strategy We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information. We design and assess our program based on the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF). This does not imply that we meet any particular technical standards, specifications, or requirements, only that we use the NIST CSF as a guide to help us identify, assess, and manage cybersecurity risks relevant to our business. Our cybersecurity risk management program has recently undergone an effort to expand and mature our security controls and documentation. These efforts include: - A security risk assessment conducted by an external supplier to help identify material cybersecurity risks to our critical systems, information, products, services, and our broader enterprise IT environment. This assessment was completed in the fourth quarter of 2024. - The implementation of revised information security program documentation and policies in the first quarter of 2024, including: o revision and implementation of a revised information security policy; o implementation of a revised incident response plan and policy; o implementation of a third-party risk management program that includes update procedures for third party vendor due diligence ; o implementation of additional periodic cybersecurity and awareness training for all of our employees, including unannounced phishing simulations; o implementation of a managed security operations center (SOC) to provide 24/7 managed detection and response (MDR) services for all corporate endpoints. 74 These efforts complement our current cybersecurity risk management program, which include a security team that is principally responsible for managing (1) our cybersecurity risk assessment processes, (2) our security controls, and (3) our response to cybersecurity incidents. We also conduct employee cybersecurity awareness training upon onboarding to the company and periodically thereafter. However, there can be no assurance that our cybersecurity risk management program and processes, including our policies, controls or procedures, will be complied with or effective in protecting our systems and information. Our cybersecurity risk management program is integrated into our overall risk management program, and shares common methodologies, reporting channels and governance processes that apply across the risk management program to other legal, compliance, strategic, operational, and financial risk areas. We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations, or financial condition. We face risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. For more information, see the section titled “Risk Factor- Our business and operations may suffer in the event of information technology system failures, cyberattacks or deficiencies in our cybersecurity.” Cybersecurity Governance Our Board considers cybersecurity risk as part of its risk oversight function and has delegated to the Audit Committee, or the Committee, oversight of cybersecurity risks, including oversight of management’s implementation of our cybersecurity risk management program. The Committee receives periodic reports from management on our cybersecurity risks. In addition, management updates the Committee, where it deems appropriate, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential. The Committee reports to the full Board regarding its activities, including those related to cybersecurity. The full Board also receives briefings from management on our cyber risk management program. Board members receive presentations on cybersecurity topics from our Senior Director of Information Technology and/or external experts as part of the Board’s continuing education on topics that impact public companies. O ur Senior Director of Information Technology, who reports to our Vice President, Corporate Affairs and Human Resources, is primarily r esponsible for assessing and managing our material risks from cybersecurity threats . Our Senior Director of Information Technology has primary responsibility for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants. Their experience includes 25 years of experience in information technology, and 8 years specifically involved in cybersecurity matters, as well as experience in security program development and review, implementation of security tools and software, security risk identification and remediation, incident identification and remediation, as well as managing enterprise risk. In addition, we rely on third party cyber security consultants and legal counsel to supplement our expertise. Our management team takes steps to stay informed about and monitor efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in our information technology environment.
Company Information
Name | scPharmaceuticals Inc. |
CIK | 0001604950 |
SIC Description | Pharmaceutical Preparations |
Ticker | SCPH - Nasdaq |
Website | |
Category | Non-accelerated filer Smaller reporting company |
Fiscal Year End | December 30 |